Literature DB >> 17409444

Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin.

Hongyan Cui1, Stephanie Darmanin, Mitsuteru Natsuisaka, Takeshi Kondo, Masahiro Asaka, Masanobu Shindoh, Fumihiro Higashino, Junji Hamuro, Futoshi Okada, Masataka Kobayashi, Koji Nakagawa, Hideyuki Koide, Masanobu Kobayashi.   

Abstract

Although hypovasculature is an outstanding characteristic of pancreatic cancers, the tumor cells survive and proliferate under severe hypoxic, glucose-deprived conditions caused by low blood supply. It is well known that the hypoxia-inducible factor-1 pathway is essential for the survival of pancreatic cancer cells under hypoxic conditions. To discover how pancreatic cancer cells adapt to glucose deprivation as well as hypoxia, we sought glucose deprivation-inducible genes by means of a DNA microarray system. We identified 63 genes whose expression was enhanced under glucose-deprived conditions at >2-fold higher levels than under normal glucose conditions. Among these genes, asparagine synthetase (ASNS) was studied in detail. Although it is known to be associated with drug resistance in leukemia and oncogenesis triggered by mutated p53, its function is yet to be determined. In this study, we found that glucose deprivation induced the overexpression of ASNS through an AMP-activated protein kinase-independent and activating transcription factor-4-dependent manner and that ASNS protects pancreatic cancer cells from apoptosis induced by glucose deprivation itself. ASNS overexpression also induced resistance to apoptosis triggered by cisplatin [cis-diammine-dichloroplatinum (CDDP)] and carboplatin, but not by 5-fluorouracil, paclitaxel, etoposide, or gemcitabine. We show that glucose deprivation induces the activation of c-jun NH(2)-terminal kinase (JNK)/stress-activated protein kinase (SAPK) in a mock transfectant but not in an ASNS transfectant. Consequently, an inhibitor of JNK/SAPK decreased the sensitivity of pancreatic cancer cells to apoptosis by glucose deprivation and CDDP. These results strongly suggest that ASNS is induced by glucose deprivation and may play a pivotal role in the survival of pancreatic cancer cells under glucose-deprived conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409444     DOI: 10.1158/0008-5472.CAN-06-2519

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines.

Authors:  Yogesh Kumar; Sybille Mazurek; Shiyu Yang; Klaus Failing; Marc Winslet; Barry Fuller; Brian R Davidson
Journal:  Tumour Biol       Date:  2010-02-24

2.  Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.

Authors:  Ran-Yi Liu; Zizheng Dong; Jianguo Liu; Ling Zhou; Wenlin Huang; Sok Kean Khoo; Zhongfa Zhang; David Petillo; Bin Tean Teh; Chao-Nan Qian; Jian-Ting Zhang
Journal:  Mol Cancer Ther       Date:  2013-08-16       Impact factor: 6.261

Review 3.  Asparagine synthetase: Function, structure, and role in disease.

Authors:  Carrie L Lomelino; Jacob T Andring; Robert McKenna; Michael S Kilberg
Journal:  J Biol Chem       Date:  2017-10-30       Impact factor: 5.157

4.  The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.

Authors:  Jiangbin Ye; Monika Kumanova; Lori S Hart; Kelly Sloane; Haiyan Zhang; Diego N De Panis; Ekaterina Bobrovnikova-Marjon; J Alan Diehl; David Ron; Constantinos Koumenis
Journal:  EMBO J       Date:  2010-05-14       Impact factor: 11.598

5.  Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.

Authors:  Eduard H Panosyan; Yuntao Wang; Peng Xia; Wai-Nang Paul Lee; Youngju Pak; Dan R Laks; Henry J Lin; Theodore B Moore; Timothy F Cloughesy; Harley I Kornblum; Joseph L Lasky
Journal:  Mol Cancer Res       Date:  2014-02-06       Impact factor: 5.852

6.  Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer.

Authors:  Kanishka Sircar; Heng Huang; Limei Hu; David Cogdell; Jasreman Dhillon; Vassiliki Tzelepi; Eleni Efstathiou; Ismaël H Koumakpayi; Fred Saad; Dijun Luo; Tarek A Bismar; Ana Aparicio; Patricia Troncoso; Nora Navone; Wei Zhang
Journal:  Am J Pathol       Date:  2012-01-11       Impact factor: 4.307

7.  Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase.

Authors:  Yi Xu; Fanzhen Lv; Xunxia Zhu; Yun Wu; Xiaoyong Shen
Journal:  Cancer Gene Ther       Date:  2016-07-22       Impact factor: 5.987

Review 8.  Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.

Authors:  Abudureyimu Tuerhong; Jin Xu; Si Shi; Zhen Tan; Qingcai Meng; Jie Hua; Jiang Liu; Bo Zhang; Wei Wang; Xianjun Yu; Chen Liang
Journal:  Cell Mol Life Sci       Date:  2021-06-15       Impact factor: 9.261

9.  Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis.

Authors:  Peng Fei Liu; Yan Wei Cao; Hai Ping Jiang; Yong Hua Wang; Xue Cheng Yang; Xin Sheng Wang; Hai Tao Niu
Journal:  Med Oncol       Date:  2014-08-02       Impact factor: 3.064

10.  Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.

Authors:  K Ameri; R Luong; H Zhang; A A Powell; K D Montgomery; I Espinosa; D M Bouley; A L Harris; S S Jeffrey
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.